162 related articles for article (PubMed ID: 3807094)
1. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
[No Abstract] [Full Text] [Related]
2. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
3. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y; Satoh T
Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
[TBL] [Abstract][Full Text] [Related]
4. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
Yamada T; Fukui I; Yokokawa M; Oshima H
Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors for progression of superficial bladder cancer].
Sato N; Sumiya H; Isaka S; Shimazaki J; Matsuzaki O
Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
[TBL] [Abstract][Full Text] [Related]
6. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
7. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
9. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
Weinstein RS; Miller AW; Coon JS
Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
[No Abstract] [Full Text] [Related]
10. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
[TBL] [Abstract][Full Text] [Related]
11. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
Yamada T; Fukui I; Yokogawa M; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
[No Abstract] [Full Text] [Related]
12. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
Kumon H; Nasu Y; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
[No Abstract] [Full Text] [Related]
13. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
[No Abstract] [Full Text] [Related]
14. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
[TBL] [Abstract][Full Text] [Related]
15. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin].
Nasu Y
Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405
[No Abstract] [Full Text] [Related]
16. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
Kobayashi H
Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of an assessment of ABH(0) isoantigens and Thomsen-Friedenreich (TF) antigen expression in patients with urinary bladder tumours.
Dobrowolski ZF; Duś D; Hałasa J; Radzikowski C
Int Urol Nephrol; 1995; 27(4):395-404. PubMed ID: 8586511
[TBL] [Abstract][Full Text] [Related]
18. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
Sasaki K
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
[TBL] [Abstract][Full Text] [Related]
19. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
Abe R
Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
[No Abstract] [Full Text] [Related]
20. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
Ohoka H; Shinomiya H; Yokoyama M; Ochi K; Takeuchi M; Utsumi S
Urol Res; 1985; 13(2):47-50. PubMed ID: 4012935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
